Streetbeat News

PBLA

Panbela Therapeutics Inc.

http://www.sunbiopharma.com/

CEO

Michael Cullen

Open

0.37

Mkt cap

1.8M

Volume

605

High

0.37

P/E Ratio

-0.01

52-wk high

1.11

Low

0.37

Div yield

N/A

52-wk low

0.30

Panbela Therapeutics reported Q2 losses of $7.95 per share, missing the analyst consensus estimate of $4.70 by 69.15%. This represents a 99.56% increase over losses from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 10, 2023 | 9:14 pm

On Monday, 149 companies reached new 52-week lows. The largest company by market cap to hit a new 52-week low was NextEra Energy (NYSE:NEE), while the smallest was Esports Entertainment (NASDAQ:GMBL). Bionano Genomics (NASDAQ:BNGO) saw the most pronounced move, with shares trading down 842.14% to hit its new 52-week low. Northwest Natural Hldg (NYSE:NWN) shares gained 0.0%, rebounding after it reached its 52-week low.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:13 pm

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Panbela Therapeutics (NASDAQ:PBLA) and maintained a price target of $16.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 4:55 pm

Panbela Therapeutics, Inc. (NASDAQ:PBLA) has opened enrollment in the UK and Germany for its ASPIRE global clinical trial in the first-line treatment of metastatic pancreatic cancer. The company plans to have all sites open for enrollment within the next couple of months, and then towards the interim data analysis in early 2024. There are approximately 95 sites planned for throughout the United States, Europe, Australia, and South Korea.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 12:18 pm

US stocks traded mixed with the Nasdaq Composite moving lower. U.S. crude oil inventories declined less than projected. Harrow Health, Panbela Therapeutics, and Carvana saw their shares rise after positive news, while Sono Group, Amarin Corporation, and Aqua Metals saw their shares drop due to negative developments.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 6:38 pm

The article lists the stocks that have gained and lost the most in Wednesday's mid-day session. Among the gainers, Biodexa Pharmaceuticals, SMX, Carvana, and Panbela Therapeutics saw significant increases due to various reasons such as patent allowances, better-than-expected sales, and asset divestitures. Among the losers, Sono Group, Amarin Corporation, Aqua Metals, and Aptevo Therapeutics saw significant decreases due to reasons such as delisting notices, organizational restructuring, and public offerings.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 5:34 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Gainers included enVVeno Medical (NVNO), 60 Degrees (SXTP), Harrow Health (HROW), Panbela Therapeutics (PBLA), DermTech (DMTK), and bluebird bio (BLUE). Losers included Amarin Corp (AMRN), Aptevo Therapeutics (APVO), ViewRay (VRAY), Genprex (GNPX), 9 Meters Biopharma (NMTR), and Context Therapeutics (CNTX).

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 5:31 pm

Panbela Therapeutics Inc (NASDAQ:PBLA) has divested certain assets in its eflornithine pediatric neuroblastoma program to US WorldMeds 1 (USWM). Panbela is set to receive up to approximately $9.5 million in non-dilutive funding for the sale. Payments will be made upon USWM's successful completion of milestones related to eflornithine's clinical development, regulatory approval, and commercial sales. Following the news, PBLA shares rose by 24.90%.

Portfolio Pulse from Vandana Singh

July 19, 2023 | 4:18 pm

U.S. stocks traded higher with the Nasdaq Composite gaining around 0.5%. M&T Bank Corporation reported better-than-expected Q2 results with a revenue of $2.60 billion, beating the consensus of $2.39 billion. Harrow Health, Panbela Therapeutics, and Carvana Co. saw their shares rise after various positive announcements. However, Sono Group, Amarin Corporation, and Aqua Metals saw their shares drop due to negative news.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 4:18 pm

US stocks traded higher with the Dow Jones gaining over 100 points. Goldman Sachs reported weaker-than-expected Q2 earnings with a 60% Y/Y plunge in EPS. SMX shares rose 39% after receiving a notice of allowance for its US patent application. Panbela Therapeutics shares rose 37% after divesting certain assets for $9.5 million. Carvana shares rose 28% after reporting better-than-expected Q2 sales. Sono Group shares dropped 33% after receiving a notice of delisting from Nasdaq. Amarin Corporation shares were down 22% after initiating an organizational restructuring program. Aqua Metals shares fell 22% after pricing a $17.4 million public offering.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 1:58 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.